Viatris to Buy Pacira BioSciences for $1.65 Billion

The Wall Street JournalView source article

Part of story

Viatris to acquire Pacira BioSciences for $1.65 billion

Drugmaker Viatris has agreed to buy pain-drug maker Pacira BioSciences for $1.65 billion in cash, expanding its portfolio of pain management therapies.

Oct 8, 20262 sourcesPain management Pharmaceutical Industry

Viatris to acquire Pacira BioSciences for $1.65 billion

Other sources for this story

Reuters

Viatris to Buy Pacira BioSciences for $1.65 Billion

Part of story

Viatris to acquire Pacira BioSciences for $1.65 billion

Other sources for this story

Viatris to buy pain therapy maker Pacira BioSciences for $1.65 billion | Reuters

Viatris to Buy Pacira BioSciences for $1.65 Billion

Part of story

Viatris to acquire Pacira BioSciences for $1.65 billion

Other sources for this story

Viatris to buy pain therapy maker Pacira BioSciences for $1.65 billion | Reuters